Logo image of ICAD.PA

ICADE (ICAD.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ICAD - FR0000035081 - REIT

21.44 EUR
+0.16 (+0.75%)
Last: 12/24/2025, 7:00:00 PM
Fundamental Rating

3

ICAD gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 41 industry peers in the Diversified REITs industry. ICAD has a bad profitability rating. Also its financial health evaluation is rather negative. ICAD has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ICAD had positive earnings in the past year.
In the past year ICAD had a positive cash flow from operations.
In multiple years ICAD reported negative net income over the last 5 years.
ICAD had a positive operating cash flow in each of the past 5 years.
ICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFICAD.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

The Return On Assets of ICAD (-1.85%) is worse than 80.49% of its industry peers.
The Return On Equity of ICAD (-4.79%) is worse than 80.49% of its industry peers.
ICAD's Return On Invested Capital of 2.76% is on the low side compared to the rest of the industry. ICAD is outperformed by 73.17% of its industry peers.
ICAD had an Average Return On Invested Capital over the past 3 years of 2.14%. This is in line with the industry average of 3.47%.
The 3 year average ROIC (2.14%) for ICAD is below the current ROIC(2.76%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROIC 2.76%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ICAD.PA Yearly ROA, ROE, ROICICAD.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 19.60%, ICAD is doing worse than 82.93% of the companies in the same industry.
ICAD's Operating Margin has declined in the last couple of years.
ICAD does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 19.6%
PM (TTM) N/A
GM N/A
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ICAD.PA Yearly Profit, Operating, Gross MarginsICAD.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICAD is destroying value.
The number of shares outstanding for ICAD remains at a similar level compared to 1 year ago.
The number of shares outstanding for ICAD has been increased compared to 5 years ago.
The debt/assets ratio for ICAD is higher compared to a year ago.
ICAD.PA Yearly Shares OutstandingICAD.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ICAD.PA Yearly Total Debt VS Total AssetsICAD.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

ICAD has an Altman-Z score of 0.64. This is a bad value and indicates that ICAD is not financially healthy and even has some risk of bankruptcy.
ICAD's Altman-Z score of 0.64 is on the low side compared to the rest of the industry. ICAD is outperformed by 60.98% of its industry peers.
ICAD has a debt to FCF ratio of 45.49. This is a negative value and a sign of low solvency as ICAD would need 45.49 years to pay back of all of its debts.
With a Debt to FCF ratio value of 45.49, ICAD is not doing good in the industry: 78.05% of the companies in the same industry are doing better.
ICAD has a Debt/Equity ratio of 0.97. This is a neutral value indicating ICAD is somewhat dependend on debt financing.
ICAD has a Debt to Equity ratio of 0.97. This is in the lower half of the industry: ICAD underperforms 75.61% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Altman-Z 0.64
ROIC/WACC0.96
WACC2.86%
ICAD.PA Yearly LT Debt VS Equity VS FCFICAD.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

ICAD has a Current Ratio of 1.06. This is a normal value and indicates that ICAD is financially healthy and should not expect problems in meeting its short term obligations.
ICAD's Current ratio of 1.06 is amongst the best of the industry. ICAD outperforms 82.93% of its industry peers.
ICAD has a Quick Ratio of 1.06. This is a bad value and indicates that ICAD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.81, ICAD is doing good in the industry, outperforming 75.61% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.06
Quick Ratio 0.81
ICAD.PA Yearly Current Assets VS Current LiabilitesICAD.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

1

3. Growth

3.1 Past

The earnings per share for ICAD have decreased strongly by -72.25% in the last year.
ICAD shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.69% yearly.
ICAD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.82%.
Measured over the past years, ICAD shows a small growth in Revenue. The Revenue has been growing by 0.64% on average per year.
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%

3.2 Future

The Earnings Per Share is expected to decrease by -2.05% on average over the next years.
The Revenue is expected to decrease by -1.58% on average over the next years.
EPS Next Y10.77%
EPS Next 2Y2.49%
EPS Next 3Y-2.05%
EPS Next 5YN/A
Revenue Next Year-6.66%
Revenue Next 2Y-2%
Revenue Next 3Y-1.58%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICAD.PA Yearly Revenue VS EstimatesICAD.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
ICAD.PA Yearly EPS VS EstimatesICAD.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 7.19, which indicates a rather cheap valuation of ICAD.
Based on the Price/Earnings ratio, ICAD is valued cheaply inside the industry as 92.68% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of ICAD to the average of the S&P500 Index (26.57), we can say ICAD is valued rather cheaply.
ICAD is valuated cheaply with a Price/Forward Earnings ratio of 6.46.
Based on the Price/Forward Earnings ratio, ICAD is valued cheaply inside the industry as 97.56% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 24.04. ICAD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.19
Fwd PE 6.46
ICAD.PA Price Earnings VS Forward Price EarningsICAD.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ICAD is valued cheaper than 92.68% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ICAD is valued a bit more expensive than 65.85% of the companies in the same industry.
Industry RankSector Rank
P/FCF 15.9
EV/EBITDA 10.57
ICAD.PA Per share dataICAD.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

ICAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A cheap valuation may be justified as ICAD's earnings are expected to decrease with -2.05% in the coming years.
PEG (NY)0.67
PEG (5Y)N/A
EPS Next 2Y2.49%
EPS Next 3Y-2.05%

4

5. Dividend

5.1 Amount

ICAD has a Yearly Dividend Yield of 5.46%, which is a nice return.
ICAD's Dividend Yield is comparable with the industry average which is at 5.07.
ICAD's Dividend Yield is rather good when compared to the S&P500 average which is at 1.88.
Industry RankSector Rank
Dividend Yield 5.46%

5.2 History

The dividend of ICAD has a limited annual growth rate of 1.04%.
Dividend Growth(5Y)1.04%
Div Incr Years1
Div Non Decr Years1
ICAD.PA Yearly Dividends per shareICAD.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

The earnings of ICAD are negative and hence is the payout ratio. ICAD will probably not be able to sustain this dividend level.
DP-185.46%
EPS Next 2Y2.49%
EPS Next 3Y-2.05%
ICAD.PA Yearly Income VS Free CF VS DividendICAD.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B

ICADE

EPA:ICAD (12/24/2025, 7:00:00 PM)

21.44

+0.16 (+0.75%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-22 2025-10-22
Earnings (Next)02-16 2026-02-16/amc
Inst Owners73.2%
Inst Owner ChangeN/A
Ins Owners0%
Ins Owner ChangeN/A
Market Cap1.63B
Revenue(TTM)1.50B
Net Income(TTM)-187.10M
Analysts52.38
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5.46%
Yearly Dividend4.84
Dividend Growth(5Y)1.04%
DP-185.46%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.87%
PT rev (3m)-2.68%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.22%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE 7.19
Fwd PE 6.46
P/S 1.09
P/FCF 15.9
P/OCF 4.98
P/B 0.42
P/tB 0.42
EV/EBITDA 10.57
EPS(TTM)2.98
EY13.9%
EPS(NY)3.32
Fwd EY15.48%
FCF(TTM)1.35
FCFY6.29%
OCF(TTM)4.31
OCFY20.09%
SpS19.67
BVpS51.19
TBVpS50.76
PEG (NY)0.67
PEG (5Y)N/A
Graham Number58.58
Profitability
Industry RankSector Rank
ROA -1.85%
ROE -4.79%
ROCE 3.87%
ROIC 2.76%
ROICexc 3.38%
ROICexgc 3.4%
OM 19.6%
PM (TTM) N/A
GM N/A
FCFM 6.86%
ROA(3y)-4.37%
ROA(5y)-2.07%
ROE(3y)-10.21%
ROE(5y)-4.69%
ROIC(3y)2.14%
ROIC(5y)2.38%
ROICexc(3y)2.49%
ROICexc(5y)2.67%
ROICexgc(3y)2.5%
ROICexgc(5y)2.68%
ROCE(3y)3.06%
ROCE(5y)3.38%
ROICexgc growth 3Y-8.78%
ROICexgc growth 5Y2.92%
ROICexc growth 3Y-8.79%
ROICexc growth 5Y2.96%
OM growth 3Y-28.23%
OM growth 5Y-3.84%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.15
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 45.49
Debt/EBITDA 9.41
Cap/Depr 211.04%
Cap/Sales 15.05%
Interest Coverage 4.1
Cash Conversion 81.96%
Profit Quality N/A
Current Ratio 1.06
Quick Ratio 0.81
Altman-Z 0.64
F-Score5
WACC2.86%
ROIC/WACC0.96
Cap/Depr(3y)678.24%
Cap/Depr(5y)1255.8%
Cap/Sales(3y)20.42%
Cap/Sales(5y)31.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-72.25%
EPS 3YN/A
EPS 5Y-9.69%
EPS Q2Q%-10.91%
EPS Next Y10.77%
EPS Next 2Y2.49%
EPS Next 3Y-2.05%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.82%
Revenue growth 3Y-1.82%
Revenue growth 5Y0.64%
Sales Q2Q%-74.49%
Revenue Next Year-6.66%
Revenue Next 2Y-2%
Revenue Next 3Y-1.58%
Revenue Next 5YN/A
EBIT growth 1Y74.88%
EBIT growth 3Y-29.53%
EBIT growth 5Y-3.23%
EBIT Next Year49.66%
EBIT Next 3Y13.32%
EBIT Next 5Y8.67%
FCF growth 1Y240.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.57%
OCF growth 3Y-11.53%
OCF growth 5Y-0.14%

ICADE / ICAD.PA FAQ

What is the ChartMill fundamental rating of ICADE (ICAD.PA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ICAD.PA.


What is the valuation status for ICAD stock?

ChartMill assigns a valuation rating of 7 / 10 to ICADE (ICAD.PA). This can be considered as Undervalued.


Can you provide the profitability details for ICADE?

ICADE (ICAD.PA) has a profitability rating of 2 / 10.


What are the PE and PB ratios of ICADE (ICAD.PA) stock?

The Price/Earnings (PE) ratio for ICADE (ICAD.PA) is 7.19 and the Price/Book (PB) ratio is 0.42.


Can you provide the dividend sustainability for ICAD stock?

The dividend rating of ICADE (ICAD.PA) is 4 / 10 and the dividend payout ratio is -185.46%.